APA (7th ed.) Citation

OS, T., G, A., L, S., MS, H., & H, M. (2026). Beyond glycemic control: Differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes. BMC endocrine disorders, 26(1), . https://doi.org/10.1186/s12902-026-02320-z

Chicago Style (17th ed.) Citation

OS, Taha, Azami G, Saed L, Hakhamaneshi MS, and Moridi H. "Beyond Glycemic Control: Differential Effects of Empagliflozin and Sitagliptin on Insulin Sensitivity and a Shared Increase in Adropin in Type 2 Diabetes." BMC Endocrine Disorders 26, no. 1 (2026). https://doi.org/10.1186/s12902-026-02320-z.

MLA (9th ed.) Citation

OS, Taha, et al. "Beyond Glycemic Control: Differential Effects of Empagliflozin and Sitagliptin on Insulin Sensitivity and a Shared Increase in Adropin in Type 2 Diabetes." BMC Endocrine Disorders, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12902-026-02320-z.